Banner Health
Tracked across 1 events · 28 articles · First seen Jul 07, 2026 · Last active Sep 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
The U.S. United States — Food and Drug Administration cleared the PrecivityAD2 blood test, developed by C2N Diagnostics, a startup founded by researchers at Washington University in St. Louis, to help evaluate Alzheimer's disease in…
Impact: Conducted blood test research including cognitively normal participants; its expert cautions against testing the worried well outside studies.
Aug 21, 2026 · 28 articles
10
Mark Yost volunteered for study Banner HealthFDA Clears C2N Alzheimer Blood Test
ERGEN INTELLIGENCE
Track Banner Health live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard